Yasutaka Watanabe

4PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 12, 2026
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.

|Jan 08, 2026
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis.

Mariano Provencio, Mark M Awad, Jonathan D Spicer

|Mar 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation.

Shintaro Kanda, Seiji Niho, Takayasu Kurata

|Nov 18, 2021
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.

Akito Hata, Isamu Okamoto, Naoki Inui

Pageof 1

Frequent Collaborators

2 joint publications

Tina Cascone

2 joint publications

Jie He

2 joint publications

Jonathan D Spicer

2 joint publications

Mariano Provencio